Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FX7Z7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,890
Award facts
- Contract value 100% obligated
- $9,889.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,889.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 24, 2025, for the supply of Entyvio 300 mg vials. The delivery order, which carries an ultimate completion date of October 16, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The award represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The Indefinite Delivery Contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities. Entyvio is a biologic medication used to treat inflammatory bowel conditions, and this order fulfills the Department of Defense's pharmaceutical requirements through DMS Pharmaceutical Group's established distribution network serving military healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FX7Z7?
SPE2DB25FX7Z7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FX7Z7 worth?
The government has obligated $9,890 on SPE2DB25FX7Z7.
Is contract SPE2DB25FX7Z7 an order under another contract?
Yes. SPE2DB25FX7Z7 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Z7 competed?
The extent of competition for SPE2DB25FX7Z7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award